Invetech Announces an Expanded Focus Within Healthcare

SAN DIEGO, CA (August 1, 2017) – To mark 30 years of product innovation success, Invetech, a leader in new product development, custom automation and contract manufacturing, is announcing an expanded focus within healthcare markets.

The evolving needs and opportunities in the vibrant healthcare sector are core to Invetech’s decision to develop and offer additional capabilities in these markets, specifically diagnostics, connected health and cell therapy manufacturing automation. Beyond healthcare, the company will continue to explore opportunities and operate projects in adjacent markets.

Over the last three decades, Invetech has been a leading product realization partner to a diverse range of clients spanning the biomedical and life sciences markets, as well as factory automation, industrial products and fast-moving consumer goods. This varied expertise has been critical in Invetech’s global expansion, including partnering with major clients such as Leica Biosystems, bioMérieux, Bio-Rad and Abbott Diagnostics.

Invetech’s plans for expansion within healthcare involve broadening the company’s core offering and capabilities, including:

Finding market differentiation through a robust experience design offering

In the current environment of ever-increasing business competitiveness and technological advancement, creating a great customer experience has become an essential element of commercial success. To help our clients develop differentiated and innovative biomedical systems and products, the company appointed Cece O’Connor as the global director of UX strategy and design to develop and grow a team of experience design engineers. Cece’s team is responsible for designing products, processes and services focused on creating the best possible interaction from the user’s point of view.

Leveraging proprietary modules for faster time to market and lower product costs

Invetech has developed a range of pre-verified subsystems and proprietary modules that can be reused and reconfigured to enable more rapid and reliable development of diagnostic instruments. The modules consist of proven technologies including configurable motion systems, software and firmware modules that combine to decrease development risk, accelerate project schedules and deliver proven reliability.

Utilizing agile methodologies to enhance development processes

Invetech is committed to applying agile methodologies across all of its diagnostics platform projects. Agile methods are key to reducing time to market, enabling greater collaboration and communication across project teams, and significantly improving product reliability.

“I am extremely proud of our 30 years of industry experience and the contributions we’ve made to society through the development of iconic products and technologies,” said Andreas Knaack, president of Invetech, when addressing the company’s strategy announcement. “As our business has grown, we have become aware of the need to focus more strongly on offering new services and capabilities to our healthcare clients. Through our adoption of agile principles and a human-centered approach to design, we continue to hone our ability to adapt to change and drive the right solutions for our clients. We intend to continue to expand deep capabilities in these rapidly evolving markets to ensure we are prepared for the rapid changes our customers are dealing with.”

Invetech will be displaying elements of its broadened healthcare market offering at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo on August 1-3 in San Diego, CA. Booth 2939.

About Invetech

Invetech has created breakthrough products and custom automation systems for more than 30 years. With experience drawn from more than 5,000 projects globally, Invetech partners with global leaders in industry to deliver product design and development, contract manufacturing and custom automation services. The company has experience in a broad range of market sectors including laboratory diagnostics, Point of Care diagnostics, life sciences and cell and advanced therapy automated production systems.